Ingrid Holm | Medical Services
Specialties
- Achondroplasia
- Androgen Insensitivity
- Birth Defects and Congenital Anomalies
- Bowlegs
- Delayed Puberty / Delayed Sexual Development
- Ehlers-Danlos Syndrome
- Fibrous Dysplasia
- Genetic Disorders
- Growth Hormone Deficiency
- Growth Problems
- Hyperparathyroidism
- Hyperthyroidism
- Hypocalcemia
- Hypopituitarism
- Hypothyroidism
- Osteogenesis Imperfecta
- Precocious Early Puberty
- Premature Adrenarche
- Prenatal Genetic Testing
- Sudden Infant Death Syndrome SIDS
- Turner Syndrome
Programs & Services
- Behavioral Health, Endocrinology, Gynecology, Urology (BEING-U)
- Bone Health Program
- Endocrinology
- Genetics and Genomics
- Robert’s Program
Languages
- English
Ingrid Holm | Education
Undergraduate School
Psychology
Brown University
1979, Providence, RI
Medical School
University of California, Los Angeles, School of Medicine
1985, Los Angeles, CA
Internship
Pediatrics
Boston Children's Hospital
1986, Boston, MA
Residency
Pediatrics
Boston Children's Hospital
1988, Boston, MA
Fellowship
Genetics and Pediatric Endocrinology
Boston Children's Hospital
1992, Boston, MA
Graduate School
MPH
Harvard School of Public Health
2003, Boston, MA
Ingrid Holm | Certifications
- American Board of Medical Genetics and Genomics
- American Board of Medical Genetics and Genomics (Clinical Genetics)
- American Board of Pediatrics (Endocrinology)
Ingrid Holm | Professional History
Ingrid A. Holm, MD, MPH is a pediatric endocrinologist and geneticist at Boston Children’s Hospital and an Associate Professor of Pediatrics at Harvard Medical School. She received her M.D. from the University of California, Los Angeles and then came to Boston Children’s Hospital where she completed her residency in pediatrics and her fellowships in genetics and pediatric endocrinology. In 2003 she completed the Harvard Pediatric Health Services Research Fellowship and received her M.P.H. in Clinical Effectiveness at the Harvard School of Public Health.
Dr. Holm’s primary clinical interest is in pediatric bone disease, particularly skeletal dysplasias and metabolic bone disease. She has had leadership roles in the American Society for Bone and Mineral Research and in the Advances In Mineral Metabolism, where she was vice president and president. Her other primary clinical interest is genetic conditions that lead to disorders of sex development, including Turner syndrome and Klinefelter syndrome.
Dr. Holm’s primary research interests are in elucidating the genetic causes of rare diseases, and in the Ethical, Legal, and Social Implications (ELSI) of returning genetic information to patients, families, and health care providers. She has been elected to the Society for Pediatric Research, is a Fellow of the American Academy of Pediatrics and of the American College of Medical Genetics and Genomics, and is a member of the Pediatric Endocrine Society.